Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 37

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 37
---
 level of care with which a reasonable
office holder in the same position would have acted under the same circumstances. The duty of loyalty requires that an office holder act
in good faith and in the best interests of the company. The duty of care includes a duty to use reasonable means to obtain (i) information
on the appropriateness of a given action submitted for his or her approval or performed by virtue of his or her position; and (ii) all
other important information pertaining to these actions. The duty of loyalty includes a duty to (i) refrain from any conflict of interest
between the performance of his or her duties in the company and his or her personal affairs; (ii) refrain from any activity that is competitive
with the business of the company; (iii) refrain from exploiting any business opportunity of the company in order to receive a personal
gain for himself or herself or others; and (iv) disclose to the company any information or documents relating to the company’s affairs
which the office holder received as a result of his or her position as an office holder.

Disclosure of Personal Interests of an Office
Holder and Approval of Certain Transactions

The Companies Law requires that an office holder promptly disclose
to the board of directors any conflict of interest (referred to under the Companies Law as a “personal interest”) that he
or she may have and all related material information known to him or her concerning any existing or proposed transaction with the company.
If it is determined that an office holder has a personal interest in a transaction, approval by the board of directors is required for
the transaction, unless the company’s articles of association provide for a different method of approval. Our articles of association
provide that for non-extraordinary interested party transactions, the board of directors may delegate its approval, or may provide a general
approval to certain types of non-extraordinary interested party transactions. Every interested party transaction requires that our board
of directors determine affirmatively that the transaction is favorable to the company. Approval first by the company’s audit committee
and subsequently by the board of directors is required for an extraordinary transaction, meaning any transaction that is not in the ordinary
course of business, not on market terms or that is likely to have a material impact on the company’s profitability, assets or liabilities.
A director and any other office holder who has a personal interest in a transaction which is considered at a meeting of the board of directors
or the audit committee may generally (unless it is with respect to a transaction which is not an